July 11th 2025
There are molecular testing gaps in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) treatment, highlighting the need for improved testing and targeted therapy integration.
Online Workshop Reveals Patient, Future Research Priorities in MDS
Authors Support Trials of Triplet Therapy in Higher-Risk MDS
Updates Are Driving the Field of MDS Forward, but Changes Still Needed